Postischemic renal oxidative stress induces an inflammatory response through PAF and oxidized phospholipids: prevention by antioxidant treatment
- 10 April 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 16 (8) , 908-910
- https://doi.org/10.1096/fj.01-0880fje
Abstract
Reperfusion injury is considered primarily an inflammatory response to oxidative stress. In vitro, oxygen free radicals induce the formation of oxidized phospholipids with platelet-activating factor (PAF) activity (PAF-like lipids). We examined the following: 1) whether PAF and PAF-like lipids are released during reperfusion; 2) the relationship between these phospholipids and oxidative damage on the one hand, and leukocyte recruitment in renal tissue on the other; and 3) whether antioxidant treatment influences the behavior of these phospholipids, the renal inflammatory response, and the outcome of postischemic acute renal failure. After 60 min of warm renal ischemia in rabbits, a release of PAF and, particularly, PAF-like lipids was seen in the first 15 min of reperfusion. In addition, the release of those phospholipids was associated with intense tissue DNA oxidation and with an increase in myeloperoxidase activity. Vitamin C was able to attenuate these postischemic oxidative changes, decrease PAF and PAF-like lipid levels, and, consequently, reduce myeloperoxidase activity. After 40 min of warm renal ischemia in rats, vitamin C treatment ameliorated renal function and structure. This is the first in vivo demonstration of the release of phospholipid oxidation products as part of an oxidative-inflammatory response after renal ischemia-reperfusion, with the release of phospholipid oxidation products significantly reduced by antioxidant treatment.Keywords
Funding Information
- Instituto de Salud Carlos III (BISCIII 99/4262)
This publication has 35 references indexed in Scilit:
- Oxidized LDL Contains Inflammatory PAF-Like PhospholipidsTrends in Cardiovascular Medicine, 2001
- Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.Journal of Clinical Investigation, 1997
- Design, Synthesis, and Structure−Activity Relationship Studies of Novel 1-[(1-Acyl-4-piperidyl)methyl]-1H-2-methylimidazo[4,5-c]pyridine Derivatives as Potent, Orally Active Platelet−Activating Factor AntagonistsJournal of Medicinal Chemistry, 1996
- Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.Journal of Clinical Investigation, 1995
- Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia modelTransplant International, 1993
- Endothelial cell interactions with granulocytes: tethering and signaling moleculesImmunology Today, 1992
- Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters.Journal of Clinical Investigation, 1991
- Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils.The Journal of cell biology, 1991
- Assessment of myocardial oxidative stress in patients after myocardial revascularizationAmerican Heart Journal, 1988